Bank Pictet & Cie Europe AG Purchases 883 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bank Pictet & Cie Europe AG grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 190,969 shares of the medical equipment provider’s stock after purchasing an additional 883 shares during the period. Intuitive Surgical comprises about 2.2% of Bank Pictet & Cie Europe AG’s holdings, making the stock its 9th largest position. Bank Pictet & Cie Europe AG’s holdings in Intuitive Surgical were worth $99,678,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of ISRG. Creative Planning increased its position in Intuitive Surgical by 9.3% in the 3rd quarter. Creative Planning now owns 68,881 shares of the medical equipment provider’s stock worth $33,839,000 after purchasing an additional 5,842 shares during the last quarter. Asset Dedication LLC boosted its stake in shares of Intuitive Surgical by 19.0% during the 3rd quarter. Asset Dedication LLC now owns 275 shares of the medical equipment provider’s stock worth $135,000 after acquiring an additional 44 shares in the last quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd boosted its stake in shares of Intuitive Surgical by 4.0% during the 3rd quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 1,681 shares of the medical equipment provider’s stock worth $826,000 after acquiring an additional 64 shares in the last quarter. Teamwork Financial Advisors LLC boosted its stake in shares of Intuitive Surgical by 0.6% during the 3rd quarter. Teamwork Financial Advisors LLC now owns 34,828 shares of the medical equipment provider’s stock worth $17,110,000 after acquiring an additional 195 shares in the last quarter. Finally, Trifecta Capital Advisors LLC boosted its stake in shares of Intuitive Surgical by 3.1% during the 3rd quarter. Trifecta Capital Advisors LLC now owns 10,859 shares of the medical equipment provider’s stock worth $5,335,000 after acquiring an additional 330 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Myriam Curet sold 408 shares of the stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 6,348 shares of company stock valued at $3,587,582. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 0.7 %

Shares of ISRG stock opened at $595.55 on Friday. The stock has a 50 day moving average of $558.58 and a two-hundred day moving average of $518.00. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a market capitalization of $212.12 billion, a P/E ratio of 92.91, a P/E/G ratio of 5.67 and a beta of 1.39.

Analyst Ratings Changes

Several analysts have recently issued reports on ISRG shares. Piper Sandler reiterated an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Leerink Partners upped their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Bernstein Bank increased their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Finally, Jefferies Financial Group increased their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.